ABSTRACT
ABSTRACT Bladder cancer is the fourth most common cancer in men and the eighth most common in women. Oncomarkers play a crucial role in early detection of bladder cancer, as well as in treatment response monitoring and prognosis. Searching for a new marker by molecular analysis is in progress because any diagnostic sensitivity and specicity enhancement is a great benet for clinical practice.
